Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

[Non-cystic fibrosis bronchiectasis [corrected]].

Ringshausen FC, Rademacher J, Welte T.

Dtsch Med Wochenschr. 2014 Apr;139(14):707-10. doi: 10.1055/s-0034-1369837. Epub 2014 Mar 25. German. No abstract available. Erratum in: Dtsch Med Wochenschr. 2014 Apr;139(14):e9.

PMID:
24668431
[PubMed - indexed for MEDLINE]
2.

Advances toward the elucidation of hypertonic saline effects on Pseudomonas aeruginosa from cystic fibrosis patients.

Michon AL, Jumas-Bilak E, Chiron R, Lamy B, Marchandin H.

PLoS One. 2014 Feb 28;9(2):e90164. doi: 10.1371/journal.pone.0090164. eCollection 2014.

PMID:
24587256
[PubMed - in process]
Free PMC Article
3.

Role of mucolytics in wet cough.

Dhar R.

J Assoc Physicians India. 2013 May;61(5 Suppl):23-7. Review. No abstract available.

PMID:
24490447
[PubMed - indexed for MEDLINE]
4.

Contamination of hypertonic saline solutions in use by cystic fibrosis patients in Israel.

Peled O, Kalamaro V, Kerem E, Shoseyov D, Blau H, Efrati O, Block C.

J Cyst Fibros. 2014 Jan 28. pii: S1569-1993(14)00003-4. doi: 10.1016/j.jcf.2014.01.001. [Epub ahead of print]

PMID:
24484849
[PubMed - as supplied by publisher]
5.

Modifying disease in cystic fibrosis: current and future therapies on the horizon.

Ong T, Ramsey BW.

Curr Opin Pulm Med. 2013 Nov;19(6):645-51. doi: 10.1097/MCP.0b013e328365ab5f. Review.

PMID:
24048086
[PubMed - indexed for MEDLINE]
6.

Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors.

Rasgado-Flores H, Krishna Mandava V, Siman H, Van Driessche W, Pilewski JM, Randell SH, Bridges RJ.

Am J Physiol Cell Physiol. 2013 Dec 1;305(11):C1114-22. doi: 10.1152/ajpcell.00166.2013. Epub 2013 Aug 28.

PMID:
23986197
[PubMed - indexed for MEDLINE]
7.
8.

Early intervention for newborns screened for cystic fibrosis.

Beydon N, Robinson PD.

Am J Respir Crit Care Med. 2013 Aug 15;188(4):409-10. doi: 10.1164/rccm.201306-1023ED. No abstract available.

PMID:
23947515
[PubMed - indexed for MEDLINE]
9.

Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.

Tam J, Nash EF, Ratjen F, Tullis E, Stephenson A.

Cochrane Database Syst Rev. 2013 Jul 12;7:CD007168. doi: 10.1002/14651858.CD007168.pub3. Review.

PMID:
23852992
[PubMed - indexed for MEDLINE]
10.

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

Snijders D, Calgaro S, Bertozzi I, Quartesan S, Kozuh I, Lunardi F, Barbato A.

Int J Immunopathol Pharmacol. 2013 Apr-Jun;26(2):529-34. Review.

PMID:
23755770
[PubMed - indexed for MEDLINE]
11.

Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.

Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M, Davis S, Brumback L, Gustafsson P, Ratjen F.

Am J Respir Crit Care Med. 2013 Aug 15;188(4):456-60. doi: 10.1164/rccm.201302-0219OC.

PMID:
23742699
[PubMed - indexed for MEDLINE]
12.

Update in cystic fibrosis 2012.

Goss CH, Ratjen F.

Am J Respir Crit Care Med. 2013 May 1;187(9):915-9. doi: 10.1164/rccm.201301-0184UP. Review. No abstract available.

PMID:
23634859
[PubMed - indexed for MEDLINE]
13.

Nebuliser systems for drug delivery in cystic fibrosis.

Daniels T, Mills N, Whitaker P.

Cochrane Database Syst Rev. 2013 Apr 30;4:CD007639. doi: 10.1002/14651858.CD007639.pub2. Review.

PMID:
23633344
[PubMed - indexed for MEDLINE]
14.

Inhaled hypertonic saline+hyaluronic acid in cystic fibrosis with asthma-like symptoms: a new therapeutic chance.

Cresta F, Naselli A, Favilli F, Casciaro R.

BMJ Case Rep. 2013 Apr 29;2013. pii: bcr2013009042. doi: 10.1136/bcr-2013-009042.

PMID:
23632183
[PubMed - indexed for MEDLINE]
15.

Cystic fibrosis papers of the year 2012.

Doull I.

Paediatr Respir Rev. 2013 May;14 Suppl 1:28-30. doi: 10.1016/j.prrv.2013.02.006. Epub 2013 Feb 26. Review.

PMID:
23452761
[PubMed - indexed for MEDLINE]
16.

Increased adherence to CFF practice guidelines for pulmonary medications correlates with improved FEV1.

Moore BM, Laguna TA, Liu M, McNamara JJ.

Pediatr Pulmonol. 2013 Aug;48(8):747-53. doi: 10.1002/ppul.22665. Epub 2012 Sep 19.

PMID:
22997186
[PubMed - indexed for MEDLINE]
17.

Nebulized hypertonic saline containing hyaluronic acid improves tolerability in patients with cystic fibrosis and lung disease compared with nebulized hypertonic saline alone: a prospective, randomized, double-blind, controlled study.

Furnari ML, Termini L, Traverso G, Barrale S, Bonaccorso MR, Damiani G, Piparo CL, Collura M.

Ther Adv Respir Dis. 2012 Dec;6(6):315-22. doi: 10.1177/1753465812458984. Epub 2012 Sep 11.

PMID:
22968159
[PubMed - indexed for MEDLINE]
18.

Current therapy for bronchiolitis.

Nagakumar P, Doull I.

Arch Dis Child. 2012 Sep;97(9):827-30. doi: 10.1136/archdischild-2011-301579. Epub 2012 Jun 25. Review.

PMID:
22734014
[PubMed - indexed for MEDLINE]
19.

Hypertonic saline in treatment of pulmonary disease in cystic fibrosis.

Reeves EP, Molloy K, Pohl K, McElvaney NG.

ScientificWorldJournal. 2012;2012:465230. doi: 10.1100/2012/465230. Epub 2012 May 3. Review.

PMID:
22645424
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pharmacologic agents for mucus clearance in bronchiectasis.

Nair GB, Ilowite JS.

Clin Chest Med. 2012 Jun;33(2):363-70. doi: 10.1016/j.ccm.2012.02.008. Epub 2012 Apr 6. Review.

PMID:
22640851
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk